|
|
|
|
|
About Us
|
|
Linda Reig Presents at CBI's 2nd Annual Forum on Bio/Pharmaceutical and Medical Device Promotional Programs
May 29, 2008
Linda P. Reig, Vice President, Compliance Services, Porzio Pharmaceutical Services, spoke at CBI's 2nd Annual Forum on Bio/Pharmaceutical and Medical Device Promotional Programs on May 29, 2008 in Philadelphia.
Ms. Reig’s presentation entitled “Effective Use of Promotional Speaker Programs that Capitalize on Clinical Trial Transparency, Targeted Publication Plans & Strategic Deployment of Medical Liaisons” discussed how the pharmaceutical landscape is rapidly changing and those setting up promotional speaker programs need to consider the larger landscape. Since the enactment of the Food & Drug Administration Amendment Act (FDAAA) of 2007 in September 2007, companies are now required to post an unprecedented amount of clinical trial data on the internet, both at the outset of clinical trials and after they are concluded. Medical liaisons are increasingly utilized to complement a company's outreach through responding to medical information inquiries and engaging in peer-to-peer scientific discussions. In addition, drug, device and biotech companies are relying on publication plans to draw attention to particular therapeutic areas, as well as treatment options. Learn about each of these industry developments and their regulatory underpinnings so that you can better coordinate your promotional speaker programs to capitalize on opportunities for product positioning in the marketplace.
Linda P. Reig is Vice President, Compliance Services, Porzio Pharmaceutical Services and Principal, Porzio, Bromberg & Newman.
|
|
| |
|